que la mortalidad a largo plazo esté relacionada sobre todo con la recidiva de la enfermedad actuaciones en una guía de seguimiento del paciente trasplantado. . documento recoge recomendaciones farmacoterapéuticas, de autocuidado, de . de las guías. • Algunos pacientes pueden comenzar con una diabetes de. Efectividad del seguimiento farmacoterapéutico en diabéticos tipo 2 clínica, se obtuvo información sobre medicamentos antidiabéticos utilizados, dosis, .. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. Objetivos: Realizar un seguimiento farmacoterapéutico y educar a pacientes conocimiento sobre la menopausia y la THR en pacientes menopaúsicas. Keywords: Hormone . ministerial que generará Guías Clínicas y tratará . stock de éste por el laboratorio que los produce. Diabetes. 38%. Depresión.
|Published (Last):||6 September 2016|
|PDF File Size:||11.49 Mb|
|ePub File Size:||19.19 Mb|
|Price:||Free* [*Free Regsitration Required]|
In total, 12 dose re-adjustments were conducted, and 10 of these were accepted. Originals Pharmaceutical care practice in patients with chronic kidney disease. Farmacoterapeutiico finding warrants conducting a more profound study of the impact expected of pharmacotherapeutic monitoring on the cost of healthcare.
In Colombia sufficient evaluations have not been conducted on the results of pharmaceutical care.
The highest prescription was for Group C, Cardiovascular System, with medications; this means that patients with CKD are administered a higher number of medications acting upon this physiological system. The main reasons for this are:. Diabetes mellitus DM is an increasingly occurring disease, which generates important complications that affect the quality of life of patients; hence, its care generates high costs, given that it is a disease of utmost interest for public health.
Discussion There was no significant difference found in CKD patients regarding gender; that is to say, male patients are at the same risk of developing it as female patients. Conclusion The NOMs with the highest prevalence were those for Non-Quantitative Insecurity; therefore, these represent a highly prevalent problem.
Universidad de Granada Grupo de Investigación en Atención Farmacéutica [WorldCat Identities]
The high frequency of the necessity NOM Causes of NOM identified in the study patients can be seen in Table 3. Cost of diabetes mellitus in Spain. Participaron pacientes, 64 intervenidos y 79 controles, con predominio de mujeres NOM are classified into problems of necessity, effectiveness, and safety; necessity NOM farmacotera;eutico untreated health problems and the effects of unnecessary medications, effectiveness NOM include the quantified and non-quantified ineffectiveness, and safety NOM include quantified diabetee non-quantified lack of safety 9 Physicians from EPSs were informed on the objectives and benefits of the pharmaceutical monitoring study and of the importance of their active participation in the program to offer complete patient care.
The status of the condition was also seguiimento for this group and a final df was conducted; thereby, detecting the NOM. The most frequent NOM causes in these four pharmacological groups were thus: Effectiveness NOMs were reviewed on the basis of the doses used and patient evolution, and Safety NOMs were detected through a comprehensive search in the Clinical Record about the presence of any ADE Adverse Drug Event by analyzing the different treatments, identifying any potential drug interactions, a subsequent pharmaceutical interview, and the evolution of their health situation.
Los pacientes de ambos grupos tomaban en promedio 6. The selection and justification for use of medications was assessed; this way, Necessity NOMs were determined. It is a useful tool for contributing to the adequate use of medications and guaranteeing their safe, effective, and economic use.
Universidad de Granada Grupo de Investigación en Atención Farmacéutica
The outcomes of the pharmaceutical interventions in the study were statistically analyzed with the STATA program version There no important variations or statistically significant differences in HbA1c values for patients in the intervention and control groups at the end of the study; although there was a reduction in values of glycated hemoglobin in the intervention group, making it convenient to suggest a similar study with a bigger population sample and a better control of losses.
Fifty-one 51 negative outcomes associated with medication were detected during the study; of these, HbA1c findings and antidiabetic medication consumption. Therefore, these points must be emphasized at the time of treating their basal conditions. Pharmacotherapeutic Monitoring PTM is defined as the professional practice in which the pharmacist assumes responsibility for the needs of the patient related to medications.
No important differences were found with the control group. Diabetes mellitus; Glucosylated hemoglobin A; Hypoglycemic agents; Pharmaceutical services; Colombia.
The patients in both groups were taking an average of 6. As the incidence of type 2 diabetes escalates, new developments offer hope for better treatments, reports. An intervention study was carried out during 19 months, between May and Januaryto evaluate the effectiveness of pharmacotherapeutic monitoring to reduce HbA1c in patients with type 2 diabetes mellitus.
The study had a sample of patients 64 intervened and 79 controls with female predominance Stemer G, Lemmens G. It was Descriptive, because the characteristics of the variables associated with the PF process were determined in patients with CKD, through the detection, prevention and solution of DRPs and NOMs and pharmaceutical interventions; and regarding time, it was Retrospective.
Though patients were being treated with the medication for their basal disease, this was not yet controlled, and this triggered a higher likelihood of presenting other NOMs, and a higher risk to their health. Along with other studies, during the initial interview, we found co-morbidities frequently associated to diabetes, such as hypertension Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: Pharmacotherapeutic records were the primary source of information and the secondary sources were the clinical histories, the status of the condition, records of medications dispensed by quantities and costs, along with the data base from the EPS services with the records of services rendered to their users, appointments with their treating physicians, authorizations for paraclinical exams requested by the physicians, among others.
NOMs can be classified into three types: Ars Pharm ; 48 1: We were able to identify in the patients in the study another less prevalent health problems. The NOMs with the highest prevalence were those for Non-Quantitative Insecurity; therefore, these represent a highly prevalent problem. Safety was the NOM with the highest number of reports in terms of Non-Quantitative Insecurity, which means that in this case, dosing was not a factor triggering this NOM. Evaluation of risk factors for development of complications in Type II diabetes in Europe.
To reduce health complications and costs in healthcare systems, strategies have been sought to contribute to such aims and which directly involve the pharmacist through a pharmaceutical care program, developed by Hepler and Strand in 8 ; its objective is the optimization of the clinical results of the drug therapy, improvement of patient quality of life, contribution to the rational use of medications, and detection, prevention, and solution to Negative Outcomes Associated with Medication NOM 9 Many of these difficulties came about because of the lack of support and commitment with the study from personnel in the participating healthcare insurance carriers.
Effectiveness NOMS were those with the highest proportion. The authors manifest and declare having no conflict of interest. There is also evidence in that the results of pharmaceutical care may lead to reduced utilization of healthcare services and to a lower number of medications prescribed Using the random number table method, we assigned the groups in random and stratified manner; in the intervention group, who had pharmacotherapeutic monitoring for 18 months; and in the control group, who were merely interviewed at the beginning and at the end of the study.
March 10, ; Accepted: The most frequently identified co-medication corresponded to antihypertensive, hypolipidemic, thryroid hormone, antiplatelet drugs, among others. Mezzano S, Aros C.
There was no significant difference found in CKD patients regarding gender; that is to say, male patients are at the same risk of developing it as female patients. Increased effectiveness of the antidiabetic therapy was not demonstrated in patients intervened farmacoyerapeutico pharmacotherapeutical monitoring, but we did obtain a reduction in healthcare costs.